Vanguard Group Inc Sio Gene Therapies Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.28 - $0.44 $28,219 - $44,344	-100,784 Reduced 5.48%	1,739,923 $765,000
Q3 2022 Nov 14, 2022	SELL	$0.28 - $0.41 $72,204 - $105,728	-257,874 Reduced 12.29%	1,840,707 $516,000
Q1 2022 May 13, 2022	SELL	$0.55 - $1.47 $27,814 - $74,339	-50,571 Reduced 2.35%	2,098,581 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $124,696 - $228,127	96,664 Added 4.71%	2,149,152 $2.77 Million
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $188,649 - $281,410	104,226 Added 5.35%	2,052,488 $4.45 Million
Q2 2021 Aug 13, 2021	BUY	$2.07 - $2.89 $4.03 Million - $5.63 Million	1,948,262 New	1,948,262 $5.32 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.